Public Health Decision Support

  • C. Jacquelinet
  • I. Belhadj
  • F. Bayer
  • E. Sauleau
  • P. Lévy
  • H. Chaudet
Part of the Health Informatics book series (HI)


This chapter presents potential uses of information and communication technologies (ICTs) for public health, with a special focus on decision-making and decisional support systems. An overview of public health sub-domains is given as potential functional areas for ICTs and business intelligence. The specifics and principles of decision-making for public health policy are explained. Main methods and observational tools used in epidemiology are overviewed. Relevant decisional support architectures are presented, ranging from data warehouse techniques, geographical information systems and simulation tools. The relevance and reusability of medico-administrative data sources is discussed, and balanced with data from registries and cohort studies in the perspective of evidence-based decisional support systems for public health. Last, public health decisional support systems are discussed as tools for translational research in public health.


Public health Decision support system Screening Prevention Health promotion Environmental health Occupational health Nutrition Health safety Drug administration Pharmacovigilance Transplantation Transfusion Evidence-based decision Uncertainty Epidemiology Registry Cohort Decisional support systems Data warehouse Simulation Geographical information Translational research 


  1. Altman DG, Bland JM (1994) Diagnostic tests 1: sensitivity and specificity. BMJ 308:1552PubMedCrossRefGoogle Scholar
  2. Andermann A (2008) Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 86(4):317–319PubMedCrossRefGoogle Scholar
  3. Ben Saïd M, le Mignot L, Mugnier C et al (2005) A multi-source information system via the internet for end-stage renal disease: scalability and data quality. Stud Health Technol Inform 116:994–999PubMedGoogle Scholar
  4. Bernstein AB, Sweeney MH (2012) Public health surveillance data: legal, policy, ethical, regulatory, and practical issues. In: CDCs vision for public health surveillance in the 21st century, morbidity and mortality weekly report MMWR 61, Suppl; July 27, pp 30–4Google Scholar
  5. Black N (2001) Evidence based policy: proceed with care. BMJ 323(7307):275–279PubMedCrossRefGoogle Scholar
  6. Blake KV, Devries CS, Arlett P et al (2012) Increasing scientific standards, independence and transparency in post-authorisation studies: the role of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Pharmacoepidemiol Drug Saf 21(7):690–696PubMedCrossRefGoogle Scholar
  7. Bourdillon F, Brücker G, Tabuteau D (2007) Définitions de la Santé Publique. in Traité de Santé Publique, 2d Edition; 1–4; Médecine-Sciences Flammarion EdGoogle Scholar
  8. Breslow NE, Day NE (1987) The role of cohort studies in cancer epidemiology. In: Breslow NE, Day NE (eds) Statistical methods in cancer research. IARC Scientific Publications, LyonGoogle Scholar
  9. Breslow NE, Day NE (2000) Fundamental measures of disease occurrence and association. In: Breslow NE, Day NE (eds) Statistical methods in cancer research, 8th edn. IARC Scientific Publications, LyonGoogle Scholar
  10. Chaudhuri S, Dayal U (1997) An overview of data ware-housing and OLAP technology. In: SIGMOD Record Web edition, vol 26(1), pp 65–74. (
  11. Corogeanu D, Willmes R, Wolke M et al (2012) Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 11 German outbreak. BMC Microbiol 12(1):1–1CrossRefGoogle Scholar
  12. Couchoud C, Stengel B, Landais P et al (2006) The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 21(2):411–418PubMedCrossRefGoogle Scholar
  13. Danchin N, Neumann A, Tuppin P et al (2011) Impact of free universal medical coverage on medical care and outcomes in low-income patients hospitalized for acute myocardial infarction: an analysis from the French National Health Insurance system. Circ Cardiovasc Qual Outcomes 4(6):619–625PubMedCrossRefGoogle Scholar
  14. Davis FG, Peterson CE, Bandiera F et al (2012) How do we more effectively move epidemiology into policy action? Ann Epidemiol 22(6):413–416PubMedCrossRefGoogle Scholar
  15. Dos Santos Silva I (1999) Cancer epidemiology: principles and methods, Overview of study designs. IARC Scientific Publications, Lyon, pp 83–101Google Scholar
  16. Food and Drug Administration (2007) Computerized systems used in clinical investigations. 2007 May, pp 1–13. Available from Consulted on 12 Dec 2012
  17. Food and Drug Administration (2005) Good pharmacovigilance practices and pharmacoepidemiologic assessment. 2005 Mar, pp 1–23. Available from Consulted on 12 Dec 2012
  18. Elveback L, Varma A (1965) Simulation of mathematical models for public health problems. Public Health Rep 80(12):1067–1076PubMedCrossRefGoogle Scholar
  19. Esteve J, Benhamou E, Raymond L (1994) Statistical methods in cancer research. IARC Scientific Publications, LyonGoogle Scholar
  20. Florin D (1999) Scientific uncertainty and the role of expert advice: the case of health checks for coronary heart disease prevention by general practitioners in the UK. Soc Sci Med 49:1269–1283PubMedCrossRefGoogle Scholar
  21. Fone D, Hollinghurst S, Temple M et al (2003) Systematic review of the use and value of computer simulation modeling in population health and health care delivery. J Public Health Med 25(4):325–335PubMedCrossRefGoogle Scholar
  22. Frendi M, Salinesi C (2003) Requirement engineering for data warehousing. In: Proceedings of the 9th international workshop on requirements engineering: foundations of software quality (REFSQ’03), Klagenfurt/Velden, Austria, 16–17 June 2003Google Scholar
  23. Frenk J, Bobadilla JL, Stern C et al (1991) Elements for a theory of the health transition. Health Transit Rev 1(1):21–38PubMedGoogle Scholar
  24. Gordon RS (1983) An operational classification of disease prevention. Public Health Rep 88(2):107–109Google Scholar
  25. Grade Working Group (2004) Grading quality of evidence and strength of recommendations. BMJ 328:1490–1494CrossRefGoogle Scholar
  26. Graham H (2010) Where is the future in public health? Milbank Q 88(2):149–168PubMedCrossRefGoogle Scholar
  27. Greene T (2009) Randomized and observational studies in nephrology: how strong is the evidence? Am J Kidney Dis 53:377–388PubMedCrossRefGoogle Scholar
  28. Hussey P, Anderson GF (2003) A comparison of single- and multi-payer health insurance systems and options for reform. Health Policy 66(3):215–228PubMedCrossRefGoogle Scholar
  29. Jensen OM, Parkin DM, MacLennan R et al (1991) Cancer registration: principles and methods. IARC Scientific Publications, LyonGoogle Scholar
  30. Lewis B, Eubank S, Abrams AM et al (2013) In silico surveillance: evaluating outbreak detection with simulation models. BMC Med Inform Decis Mak 13(1):12PubMedCrossRefGoogle Scholar
  31. Lis Y, Roberts MH, Kamble S et al (2012) Comparisons of food and drug administration and European medicines agency risk management implementation for recent pharmaceutical approvals: report of the international society for pharmacoeconomics and outcomes research risk benefit management working group. Value Health 15(8):1108–1118PubMedCrossRefGoogle Scholar
  32. Maria A (1997) Introduction to modeling and simulation. In: Proceedings of the 97 winter simulation conference, Atlanta, 7–10 Dec, pp 1–7Google Scholar
  33. Minkler M (1989) Health education, health promotion and the open society: an historical perspective. Health Educ Behav 16:17–30CrossRefGoogle Scholar
  34. NIH (2013) Consulted on 24 Jun 2013
  35. Pierce N (2012) Classification of epidemiological study designs. Int J Epidemiol 41(2):393–397CrossRefGoogle Scholar
  36. Poole J, Chang D, Tolbert D et al (2002) Common Warehouse Metamodel, an introduction to the standard for data warehouse integration. Wiley, New YorkGoogle Scholar
  37. Pruett TL, Blumberg EA, Cohen DJ et al (2012) A consolidated biovigilance system for blood, tissue and organs: one size does not fit all. Am J Transplant 12(5):1099–1101PubMedCrossRefGoogle Scholar
  38. Quan H, Li B, Duncan Saunders L et al (2008) Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 43(4):1424–1441PubMedCrossRefGoogle Scholar
  39. Robertson C, Nelson TA (2010) Review of software for space-time disease surveillance. Int J Health Geogr 9:16PubMedCrossRefGoogle Scholar
  40. Rose G, Barker D (1978a) What is epidemiology? BMJ 2:803–804PubMedCrossRefGoogle Scholar
  41. Rose G, Barker D (1978b) Rates. BMJ 2:941–942PubMedCrossRefGoogle Scholar
  42. Rose G, Barker D (1978c) Comparing rates. BMJ 2:1282–1283PubMedCrossRefGoogle Scholar
  43. Rychetnik L, Bauman A, Laws R et al (2012) Translating research for evidence-based public health: key concepts and future directions. J Epidemiol Community Health 66(12):1187–1192PubMedCrossRefGoogle Scholar
  44. Strang WN, Tuppin P, Atinault A et al (2005) The French organ transplant data system. Stud Health Technol Inform 116:77–82PubMedGoogle Scholar
  45. Szklo M, Nieto FJ (2012) Measuring disease occurrence. In: Epidemiology: beyond the basics, 3rd edn. Jones & Barlett Learning Publishers, BurlingtonGoogle Scholar
  46. Tuppin P, de Roquefeuil L, Weill A et al (2010) French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique 58(4):286–290PubMedCrossRefGoogle Scholar
  47. Vanhoorne MN, Vanachter OV, De Ridder MP (2006) Occupational health care for the 21st century: from health at work to workers’ health. Int J Occup Environ Health 12(3):278–285PubMedGoogle Scholar
  48. Victora CG, Habicht J-P, Bryce J (2004) Evidence-based public health: moving beyond randomized trials. Am J Public Health 4(3):400–405CrossRefGoogle Scholar
  49. Walters L (2012) Genetics and bioethics: how our thinking has changed since 1969. Theor Med Bioeth 33(1):83–95PubMedCrossRefGoogle Scholar
  50. Winslow C-EA (1926) Public health at the crossroads. Am J Public Health 16(11):1075–1085CrossRefGoogle Scholar
  51. Worden R, Scott P (2011) Simplifying HL7 Version 3 messages. Stud Health Technol Inform 169:709–713PubMedGoogle Scholar
  52. World Health Organization (1998) Therapeutic patient education. Consulted on 12 Dec 2012
  53. World Health Organization (1999) Overview of the environment and health in Europe in the 90s. Consulted on 12 Dec 2012
  54. World Health Organization (2007a) Everybody’s business: strengthening health systems to improve health outcomes. Consulted on 12 Dec 2012
  55. World Health Organization (2007b) The world health report 2007: a safer future. Consulted on 12 Dec 2012
  56. Zarin DA, Tse T, Williams RJ et al (2011) The results database – update and key issues. N Engl J Med 364(9):852–860PubMedCrossRefGoogle Scholar
  57. Zerhouni E (2005) Translational and clinical science – time for a new vision. N Engl J Med 353(15):1621–1623PubMedCrossRefGoogle Scholar
  58. Ziegler A, Koch A, Krockenberger K et al (2012) Personalized medicine using DNA biomarkers: a review. Hum Genet 131(10):1627–1638PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France 2014

Authors and Affiliations

  • C. Jacquelinet
    • 1
  • I. Belhadj
    • 2
  • F. Bayer
    • 2
  • E. Sauleau
    • 3
  • P. Lévy
    • 3
  • H. Chaudet
    • 4
  1. 1.Agence de la biomédecineDirection Médicale et ScientifiqueSaint Denis la PlaineFrance
  2. 2.Agence de la biomédecineSaint Denis la PlaineFrance
  3. 3.Département de Santé Publique des HUSHôpital CivilStrasbourgFrance
  4. 4.Faculte de MedecineUMR 912 - SESSTIM - INSERM / IRD/ Aix-Marseille UniversitéMarseilleFrance

Personalised recommendations